Episode summary
Andrew Left Found Guilty in Case That Spooked Short Sellers | Bloomberg Businessweek
Summary
The episode opens with the guilty verdict for short seller Andrew Left, whom the host says was convicted of using “disingenuous social media post to manipulate stocks.” A guest explains that prosecutors argued Left traded opposite to his public commentary across more than a dozen companies, including Twitter, Facebook and Nvidia, and says the case could chill short selling because it leaves the line unclear between legitimate bearish research and manipulation.
The conversation then turns to artificial intelligence skepticism, where a guest argues that the market is confusing a semiconductor rally with a profitable AI business. He says major model makers lack a clear path to profitability, that customers may be unable to measure AI’s true cost, and that public markets could be shocked when these companies eventually file.
Later segments shift to Bank of America’s view of the middle market, where a guest says clients are using M&A to grow, manage supply chains and expand globally, and that AI adoption is focused on customer experience, frontline productivity, process improvement and efficiency. The final interview explores a longevity biotech developing a drug aimed at necrosis, with the founders saying they hope to move into clinical trials for kidney disease as a “gateway” indication.
Key takeaways
- A guest says the Andrew Left verdict may chill short sellers because it could create new enforcement lines without clear regulations.
- The guest on AI argues that OpenAI, Anthropic and similar firms are being valued ahead of any proven return on investment.
- Wendy Stewart says middle-market clients are using M&A, supply-chain changes and AI to drive growth and efficiency.
- Dr. Karina Kern says Longevity is targeting necrosis as a root mechanism of aging and plans a kidney-disease clinical trial first.
Notable quotes
“He was found guilty of using disingenuous social media post to manipulate stocks”
“It wasn't just his shorts that were on trial here. some of his long bets as well”
“I think people are conflating a semiconductor rally with an underlying successful business which doesn't really exist”
“AI doesn't have an ROI”
“our clients are thinking about how to use AI to do four things”
How the episode opens
Bloomberg Audio Studios, podcasts, radio, news. — This is Bloomberg Business Week Daily. Reporting from the magazine that helps global leaders stay ahead with insight on the people, companies, and trends shaping today's complex economy. Plus, global business, finance, and tech news as it happens. The Bloomberg Business Week Daily podcast with Carol Masser and Tim Stenc on Bloomberg Radio.
This is one of the most read stories on the Bloomberg terminal in the past day. It crossed late yesterday. We got more details on it overnight.
It's about the famed short seller Andrew Left. He faces the possibility of decades behind bars. He was found guilty of using disingenuous social media post to manipulate stocks.
In a landmark case, it threatens to chill a broader trading strategy that's just loathed by corporate executives. We've got Eric Larson with us. He's US legal reporter for Bloomberg News.
He joins us from Los Angeles. Eric, just just remind us who Andrew Left is, what Citron Research made a name doing.
Sure. As you said, he uh he he grew a big following on Twitter actually is where he got so many followers tracking everything he was saying about companies that he was researching through his Citron research. Um he made some good calls back in the day on a few companies that gained him extra followers and really this this group that was following him is who he tried to manipulate here according to the justice department.
So you mentioned this trading strategies that's loathed by companies. It has to do with building a short position on a company and then trashing it in a research report or tweets in Mr. Left's case.
And so the government said that Mr. Left went a little beyond just doing that. So, it's a it's a really, like you said, it's a landmark case and the short selling industry is really wondering what it means.
From the episode’s captions: roughly the first two minutes, lightly cleaned. Keep watching on YouTube →
Topics
- short selling crackdown
- social media market manipulation
- legal case and sentencing
- banking trends
- ai skepticism
Companies and tickers mentioned
- BAC
- Bank of America
- EZ Primary Research
- LinkGevity
Watch the episode
Summary, takeaways and quote selection by Octagon. Quotes are short excerpts; the full conversation is in the episode.
More from Bloomberg Businessweek Daily
-
Bloomberg Businessweek Weekend - November 13th, 2026 | Bloomberg Businessweek -
Inside Jensen Huang’s Final Hours as Nvidia CEO | Bloomberg Businessweek -
Jensen Huang's Exit Kicks Off Nvidia Strategy Reset | Bloomberg Businessweek -
Special Episode: Bobby Jain on Why He Chose Millennium Again | Bloomberg Businessweek -
Bloomberg Businessweek Daily Podcast: Jensen’s Nvidia Departure -
Take-Two Releasing Long-Awaited Grand Theft Auto VI Next Week | Bloomberg Businessweek
Bloomberg Businessweek Daily, this episode and its artwork belong to Bloomberg. Octagon is not affiliated with the show; this page is an independent summary.